ArticlePloS one2013

Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis.

Aadithya Arumugam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.